2247995-37-3 lanzetinib mezilate

Taikymas:

Lanzetinib mesylate is mainly used to treat non-small cell lung cancer (NSCLC) patients carrying specific epidermal growth factor receptor (EGFR) gene mutations. This drug targets and inhibits EGFR mutant proteins (such as T790M mutation), blocking tumor cell growth signals and delaying disease progression.

Sinonimai:

Lazertinibo mezilato bevandenis

2- propenamidas, N-[{5- [[{4- [{4- [(dimetilamino) metil] -3- fenil -1 h-pirazol {{8} } yl] -2- pirimidinil] amino] -4- metoksi -2- ({4- morfolinil) fenil]-, metanesulfonatas (1: 1)

2247995-37-3

Populiarus Žymos: 2247995-37-3 lanzetinib mezilate, Kinija 2247995-37-3 lanzetinib mezilato gamintojai, tiekėjai